New strategies for doping control

Journal of Sports Sciences

Volumn 26, Issue 5, 2008, Pages 441-445

  Lippi, Giuseppe ^a   Banfi, Giuseppe ^b   Franchini, Massimo ^c   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Anti doping; Doping; Laboratory testing; Sports

Indexed keywords

ALCOHOL; CHORIONIC GONADOTROPIN; GROWTH HORMONE; RECOMBINANT ERYTHROPOIETIN; RECREATIONAL DRUG;

ARTICLE; ATHLETE; COMPETITION; DIET SUPPLEMENTATION; DOPING; GOVERNMENT; HEALTH CARE SYSTEM; LABORATORY TEST; MOTOR PERFORMANCE; PREVALENCE; PROVOCATION TEST; REFERENCE VALUE;

BUDGETS; DIETARY SUPPLEMENTS; DOPING IN SPORTS; HUMANS; LEGISLATION, DRUG; PUBLIC POLICY; REFERENCE VALUES; SPORTS;

EID: 39449105069     PISSN: 02640414     EISSN: 1466447X     Source Type: Journal    
DOI: 10.1080/02640410701624556     Document Type: Article

References (29)

1. Alaranta, A., Alaranta, H., Holmila, J., Palmu, P., Pietila, K. and Helenius, I. (2006) Self-reported attitudes of elite athletes towards doping: Differences between types of sport. International Journal of Sports Medicine, 27, pp. 842-846.
2. Azzazy, H. M., Mansour, M. M. and Christenson, R. H. (2005) Doping in the recombinant era: Strategies and counterstrategies. Clinical Biochemistry, 38, pp. 959-965.
3. Banfi, G. and Dolci, A. (2003) Preanalytical phase of sport biochemistry and haematology. Journal of Sports Medicine and Physical Fitness, 43, pp. 223-230.
4. Blendon, R. J., Hunt, K., Benson, J. M., Fleischfresser, C. and Buhr, T. (2006) Understanding the American public's health priorities: A 2006 perspective. Health Affairs (Project Hope), 25, pp. w508-w515.
5. Boyko, R. H., Boyko, A. R. and Boyko, M. G. (2007) Referee bias contributes to home advantage in English Premiership football. Journal of Sports Sciences, 25, pp. 1185-1194.
6. Du, H. and Cheng, J. (2006) Protein chips for high-throughput doping screening in athletes. Expert Review of Proteomics, 3, pp. 111-114.
7. Fraser, A. D. (2004) Doping control from a global and national perspective. Therapeutical Drug Monitoring, 26, pp. 171-174.
8. Gauthier, J. (2006) The heart and doping. Archives des Maladies du Coeur et des Vaisseaux, 99, pp. 1126-1129.
9. Guidi, G. C., Lippi, G., Solero, G. P., Poli, G. and Plebani, M. (2006) Managing transferability of laboratory data. Clinica Chimica Acta, 374, pp. 57-62.
10. Handelsman, D. J. (2006) Clinical review: The rationale for banning human chorionic gonadotropin and estrogen blockers in sport. Journal of Clinical Endocrinology and Metabolism, 91, pp. 1646-1653.
11. Kamber, M. and Mullis, P. E. (2007) Doping in adolescence. Therapeutische Umschau, 64, pp. 83-89.
12. Kayser, B., Mauron, A. and Miah, A. (2007) Current anti-doping policy: A critical appraisal. BMC Medical Ethics, 8, p. 2.
13. Laure, P. and Binsinger, C. (2007) Doping prevalence among preadolescent athletes: A four-year follow-up. British Journal of Sports Medicine, 41, pp. 660-663.
14. Lippi, G. and Banfi, G. (2006) Blood transfusions in athletes: Old dogmas, new tricks. Clinical Chemistry and Laboratory Medicine, 44, pp. 1395-1402.
15. Lippi, G., Franchini, M. and Guidi, G. C. (2005) Cobalt chloride administration in athletes: A new perspective in blood doping?. British Journal of Sports Medicine, 39, pp. 872-873.
16. Lippi, G., Franchini, M. and Guidi, G. C. (2007) Tour de chaos. British Journal of Sports Medicine, 41, pp. 625-626.
17. Lippi, G. and Guidi, G. (1999) Doping and sports. Minerva Medica, 90, pp. 345-357.
18. Lippi, G., Mattiuzzi, C. and Guidi, G. (2004) Prevention of doping in sports: Epidemiological issues and ethical implications. Epidemiologia e Prevenzione, 28, pp. 178-183.
19. Lippi, G., Salvagno, G. L., Solero, G. P. and Guidi, G. C. (2006) The influence of the tourniquet time on hematological testing for antidoping purposes. International Journal of Sports Medicine, 27, pp. 359-362.
20. Martello, S., Felli, M. and Chiarotti, M. (2007) Survey of nutritional supplements for selected illegal anabolic steroids and ephedrine using LC-MS/MS and GC-MS methods, respectively. Food Additives and Contaminants, 24, pp. 258-265.
21. Maughan, R. J. (2005) Contamination of dietary supplements and positive drug tests in sport. Journal of Sports Sciences, 23, pp. 883-889.
22. Maughan, R. J., King, D. S. and Lea, T. (2004) Dietary supplements. Journal of Sports Sciences, 22, pp. 95-113.
23. McDuff, D. R. and Baron, D. (2005) Substance use in athletics: A sports psychiatry perspective. Clinics in Sports Medicine, 24, pp. 885-897.
24. McHugh, C. M., Park, R. T., Sönksen, P. H. and Holt, R. I. (2005) Challenges in detecting the abuse of growth hormone in sport. Clinical Chemistry, 51, pp. 1587-1593.
25. Saugy, M., Avois, L., Saudan, C., Robinson, N., Giroud, C. and Mangin, P. (2006) Cannabis and sport. British Journal of Sports Medicine, 40, pp. i13-i15.
26. Savulescu, J. (2006) Justice, fairness, and enhancement. Annals of the New York Academy of Sciences, 1093, pp. 321-338.
27. Striegel, H., Rossner, D., Simon, P. and Niess, A. M. (2005) The World Anti-Doping Code 2003: Consequences for physicians associated with elite athletes. International Journal of Sports Medicine, 26, pp. 238-243.
28. Thevis, M., Geyer, H., Mareck, U., Sigmund, G., Henke, J. and Henke, L. (2007) Detection of manipulation in doping control urine sample collection: A multidisciplinary approach to determine identical urine samples. Analytical and Bioanalytical Chemistry, 388, pp. 1539-1543.
29. Thevis, M. and Schanzer, W. (2007) Mass spectrometry in sports drug testing: Structure characterization and analytical assays. Mass Spectrometry Reviews, 26, pp. 79-107.